Which has the lower trailing P/E, CI or EW?

CI has the lower trailing P/E: CI trades at 11.49 and EW at 51.60. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, CI or EW?

Over the past five years, CI grew revenue faster — CI at a 11.11% CAGR versus EW at 5.75%.

Does CI or EW pay a bigger dividend?

CI pays a dividend (2.21% yield), while EW has no payments in the available dividend history.

Is CI or EW more profitable?

EW runs the higher net margin — CI at 2.27% versus EW at 15.43%.

How have CI and EW total returns compared?

Over the past 10 years, CI delivered 8.72% and EW delivered 8.59% annualized total return. Past performance doesn't predict future results.

Cigna Corporation (CI) vs Edwards Lifesciences Corporation (EW)

A side-by-side comparison of Cigna Corporation and Edwards Lifesciences Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 23, 2026. Differences are shown without an overall score or investment verdict.

Cigna Corporation

$73.33B

$277.51HealthcareAt close: Aug 21, 2026, 4:00 PM ET

Edwards Lifesciences Corporation

$51.70B

$89.79HealthcareAt close: Aug 21, 2026, 4:00 PM ET

Total return — CI vs EW

growth of $100 · dividends reinvested · last 10y

CI +132.9% (+8.8%/yr)EW +134.7% (+8.9%/yr)EW compounded faster over this window

CI EW

CI vs EW: by the numbers

•CI is the larger company ($73.33B vs $51.70B market cap).
•CI trades at the lower trailing earnings multiple (11.49 vs 51.60 P/E), one valuation lens rather than an overall verdict.
•EW converts more revenue to profit (15.43% vs 2.27% net margin).
•CI grew revenue faster over the past five years (11.11% vs 5.75% CAGR).
•CI pays a dividend (2.21% yield), while EW has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	CI	EW
P/E ratio	11.49	51.60
Forward P/E	9.10	29.92
P/S ratio	0.26	7.96
P/B ratio	1.72	4.88
EV / EBITDA	8.01	24.89
FCF yield	12.44%	2.76%

Profitability

Metric	CI	EW
Gross margin	11.66%	77.98%
Operating margin	3.46%	28.09%
Net margin	2.27%	15.43%
ROE	15.05%	9.46%
ROIC	7.69%	10.22%

Dividends

Metric	CI	EW
Dividend yield	2.21%	N/A
Payout ratio	27.53%	N/A

Growth (annualized)

Metric	CI	EW
Revenue CAGR (5Y)	11.11%	5.75%
EPS CAGR (5Y)	-0.76%	6.87%
FCF CAGR (5Y)	-1.95%	6.41%
Total return CAGR (5Y)	7.94%	-5.47%

Frequently asked

Which has the lower trailing P/E, CI or EW?: CI has the lower trailing P/E: CI trades at 11.49 and EW at 51.60. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, CI or EW?: Over the past five years, CI grew revenue faster — CI at a 11.11% CAGR versus EW at 5.75%.
Does CI or EW pay a bigger dividend?: CI pays a dividend (2.21% yield), while EW has no payments in the available dividend history.
Is CI or EW more profitable?: EW runs the higher net margin — CI at 2.27% versus EW at 15.43%.
How have CI and EW total returns compared?: Over the past 10 years, CI delivered 8.72% and EW delivered 8.59% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CI analysis Full EW analysis Interactive comparison tool

Dig into the metrics

Cigna P/E ratio Edwards Lifesciences P/E ratio Cigna dividend yield Cigna ROE Edwards Lifesciences ROE Cigna operating margin Edwards Lifesciences operating margin Cigna revenue growth Edwards Lifesciences revenue growth Cigna free cash flow Edwards Lifesciences free cash flow

Cigna & Edwards Lifesciences appear in these rankings

Highest Dividend Yield Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 23, 2026.